Search
Filter Results
- Resource Type
- Book2
- Article1
- Book Digital1
- Book Print1
- Result From
- Lane Catalog1
- PubMed1
- SearchWorks (biomedical subset) 1
-
Year
- Journal Title
- Acta Pathol Microbiol Scand B1
Search Results
Sort by
- BookPatricia A. Ganz, editor.Summary: In collaboration with the Breast Cancer Research Foundation (BCRF), this timely volume provides a comprehensive review on all areas of breast cancer survivorship research, highlighting research that is underway or in development. The range of topics covered include the biology and management of fatigue and cognitive dysfunction on breast cancer survivorship, the biology and management of Neuropathy and Arthralgias, the ongoing research on the biology of diet and lifestyle interventions in survivors, and more. With the tremendous growth in the number of breast cancer survivors, researchers have moved beyond describing the outcomes of breast cancer treatments and are focusing their research on understanding the mechanisms underlying the development of the late effects of breast cancer treatment, as well as the development and evaluation of interventions to mitigate some of the persistent symptoms--topics which are also explored in this volume. In addition, current research on how to improve survivorship and reduce recurrence of breast cancer through behavioral and lifestyle modifications is also discussed.
Contents:
Introduction: Breast Cancer Survivorship Research- Where are we today?
Special Issues in Younger Women
Special Issues in Older Women
Breast Cancer Among Special Populations: Disparities in Care Across the Cancer Control Continuum
Symptoms: Fatigue and Cognitive Dysfunction
Symptoms: Chemotherapy-Induced Peripheral Neuropathy
Symptoms: Aromatase Inhibitor Induced Arthralgias
Symptoms: Lymphedema
Symptoms: Menopause, Infertility and Sexual Health
Host Factors and Risk of Breast Cancer Recurrence: Genetic, epigenetic and biologic factors and breast cancer outcomes
Comorbidities and their Management: Potential Impact on Breast Cancer Outcomes
Modifiable Lifestyle Factors and Breast Cancer Outcomes: Current Controversies and Research Recommendations
Risk reduction from Weight management and physical activity interventions
Prevention and Treatment of Cardiac Dysfunction in Breast Cancer Survivors
Psychological Adjustment in Breast Cancer Survivors
Living with metastatic breast cancer
Quality of care, including survivorship care plans.Digital Access Springer 2015Access via Advances in experimental medicine and biology ; 2015; 862.LocationVersionCall NumberItems - ArticleSchiøtz PO, Høiby N.Acta Pathol Microbiol Scand B. 1979 Dec;87(6):345-51.Serum and sputum sol phase from 23 patients with cystic fibrosis (CF) were examined for occurrence and titres of precipitins against Haemophilus influenzae and Staphylococcus aureus by means of crossed immunoelectrophoresis with intermediate gel. The patients had from four to nine H. influenzae precipitins in serum and in most cases fewer precipitins in sputum, but, on an average, there was no difference between the titres of the antibodies in serum and sputum. Most of the antibodies were cross-reactive with other species, notably those of the Haemophilus genus. S. aureus precipitins were generally found in higher numbers in serum than in sputum, but, on an average, the titre of the precipitins in sputum was higher than in serum. Three of the precipitins were detectable only in sputum and not in serum, and one of these is a S. aureus-specific precipitin. Most of the antibodies were cross-reactive with other species, and these antibodies were often present in sputum in much higher titres than in the corresponding sera. Antibodies against teichoic acid of the S. aureus cell wall could not be demonstrated in sputum, while they were present in 22 sera. The possible role of the local pulmonary humoral immune response in protective immunity and in the pathology of the lung disease in CF is discussed.